Anthony Mirhaydari

Anthony Mirhaydari

Anthony Mirhaydari is founder of the Edge and Edge Pro investment advisory newsletters.

He is an independent investment columnist with work appearing at Investorplace, The Fiscal Times, CBS News MoneyWatch, MSN Money, Yahoo Finance, and Dow Jones MarketWatch. He started covering the markets and the economy in the media in 2008 in the midst of the greatest financial crisis in generations.

Previously, he was a senior research analyst with Markman Capital Insight, an advisory and money management firm, and a business consulting analyst with Moss Adams focusing on the financial-services industry.

Recent Articles

5 Biotech Stocks to Buy for a Q4 Rally

Biotech stocks have been a consistent area of weakness, but things are turning around for the battered sector.

Apple Inc. Earnings Solid as Stocks Await Fed

Big Pharma lifted healthcare, but Apple's earnings beat after the bell was too late to save the Nasdaq.

Stocks Mixed as Apple Earnings Loom

The odds of a 2015 rate hike continue to dwindle, while energy experiences heavy weakness. For Tuesday, all eyes are on Apple earnings.

5 Tech Stocks That Should Clock the Market

Big Tech has been putting up solid gains this earnings season, but you've likely missed out on any upside in the stocks that have reported already. Fear not, here are five tech stocks set to outperform the market in the near term.

Stocks Soar on China Rate Cut, Tech Earnings

Big Tech earnings and some much needed good news out of China sent stocks going higher Friday.

Stocks Soar on Earnings, ECB Hopes

We're likely on the verge of an attack on the market's July highs as a powerful "Santa Claus" rally starts materializing. Two potential hurdles: A surprise interest rate hike from the Federal Reserve or chaos surrounding the debt ceiling in early November.

Stocks Drop on Biotech Blues

The markets took another turn for the worst as Citron Research calls out a former Wall Street darling as possibly the Enron of biotech.

Stocks Wilt on Earnings and Oil Decay

The short rally in stocks was stopped on several below-average earnings reports coupled with a downturn in oil. Housing starts, however, saw a nice gain.

5 Bank Stocks That Are Ready to Open the Vault

The Federal Reserve's hesitancy to raise rates has set the stage for nice rebound rallies in bank stocks across the board. Here are five to watch closely.

Stocks Inch Higher Ahead of Earnings

Better-than-expected GDP figures, retail sales and, yes, Oprah Winfrey helped push stocks higher today.